Financial Advocates Investment Management Danaher Corp Transaction History

Financial Advocates Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$225.08 - $271.69 $451,060 - $544,466	-2,004 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$212.38 - $245.9 $12,955 - $14,999	-61 Reduced 2.95%	2,004 $451,000
Q4 2020 Feb 12, 2021	BUY	$212.5 - $245.46 $13,175 - $15,218	62 Added 3.1%	2,065 $458,000
Q3 2020 Nov 04, 2020	BUY	$177.16 - $215.33 $2,303 - $2,799	13 Added 0.65%	2,003 $431,000
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $2,316 - $3,182	-18 Reduced 0.9%	1,990 $352,000
Q1 2020 Apr 29, 2020	BUY	$121.39 - $169.05 $19,907 - $27,724	164 Added 8.89%	2,008 $278,000
Q4 2019 Feb 13, 2020	BUY	$133.47 - $153.48 $189,927 - $218,402	1,423 Added 338.0%	1,844 $283,000
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $96,557 - $111,511	-1,018 Reduced 70.74%	421 $43,000
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $141,209 - $156,707	1,439 New	1,439 $0

2,511

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.